KAVANAGH SARAH B has filed 5 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 20338 shares of Bausch & Lomb Corp ($BLCO) on May 27, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Bausch & Lomb Corp | $BLCO | KAVANAGH SARAH B | Director | A | Common Shares, No Par Value | 20338 | $0.00 | 53,699.0000 | 352,470,796 | 60.96% | 0.01% |
| May 16, 2025 | Bausch Health Companies Inc. | $BHC | KAVANAGH SARAH B | Director | A | Common Shares, No Par Value | 54347 | $0.00 | 236,359.0000 | 368,000,000 | 29.86% | 0.01% |
| Aug. 2, 2024 | Bausch & Lomb Corp | $BLCO | KAVANAGH SARAH B | Director | A | Common Shares, No Par Value | 14696 | $0.00 | 33,361.0000 | 350,500,000 | 78.74% | 0.00% |
| May 17, 2024 | Bausch Health Companies Inc. | $BHC | KAVANAGH SARAH B | Director | A | Common Shares, No Par Value | 35360 | $0.00 | 182,012.0000 | 364,900,000 | 24.11% | 0.01% |
| May 19, 2023 | Bausch Health Companies Inc. | $BHC | KAVANAGH SARAH B | Director | A | Common Shares, No Par Value | 29205 | $0.00 | 146,652.0000 | 362,000,000 | 24.87% | 0.01% |